Indication: (1) Treatment of chemical acidosis. For the treatment of mild to moderate chemical acidosis, oral administration is preferred. For severe chemical acidosis, intravenous drip should be used, such as in severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. (2) Alkalization of urine. Used for the prevention of uric acid kidney stones, reducing the renal toxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. (3) As an antacid, it treats symptoms caused by excessive gastric acid. (4) Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates, and methanol. However, this product is contraindicated for gastric lavage in case of ingestion of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which can lead to acute gastric dilatation or even gastric rupture.

Indication: (1) Treatment of chemical acidosis. For the treatment of mild to moderate chemical acidosis, oral administration is preferred. For severe chemical acidosis, intravenous drip should be used, such as in severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. (2) Alkalization of urine. Used for the prevention of uric acid kidney stones, reducing the renal toxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. (3) As an antacid, it treats symptoms caused by excessive gastric acid. (4) Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates, and methanol. However, this product is contraindicated for gastric lavage in case of ingestion of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which can lead to acute gastric dilatation or even gastric rupture.

Indication: (1) Treatment of chemical acidosis. For the treatment of mild to moderate chemical acidosis, oral administration is preferred. For severe chemical acidosis, intravenous drip should be used, such as in severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. (2) Alkalization of urine. Used for the prevention of uric acid kidney stones, reducing the renal toxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. (3) As an antacid, it treats symptoms caused by excessive gastric acid. (4) Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates, and methanol. However, this product is contraindicated for gastric lavage in case of ingestion of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which can lead to acute gastric dilatation or even gastric rupture.

Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.

Indication: 1. Treatment of metabolic acidosis. For the treatment of mild to moderate metabolic acidosis, oral administration is preferred. Severe metabolic acidosis should be treated by intravenous drip, such as severe kidney disease, circulatory failure, cardiopulmonary resuscitation, extracorporeal circulation, severe primary lactic acidosis, diabetic ketoacidosis, etc. 2. Alkalize urine. Used for the prevention of uric acid kidney stones, reducing the nephrotoxicity of sulfonamide drugs, and acute hemolysis to prevent hemoglobin deposition in the renal tubules. 3. As an antacid, it treats symptoms caused by excessive gastric acid. 4. Intravenous drip has a non-specific therapeutic effect on certain drug poisonings, such as poisoning by barbiturates, salicylates and methanol. However, this product is contraindicated for gastric lavage when swallowed in case of strong acid poisoning, because this product reacts with strong acid to produce a large amount of carbon dioxide, which leads to acute gastric dilatation or even gastric rupture.

Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive production of uric acid. 2. Patients with recurrent or chronic gout. 3. Gout stones. 4. Uric acid kidney stones and/or uric acid nephropathy. 5. Hyperuricemia with renal insufficiency.

Indication: It is used for ① primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; ② recurrent or chronic gout; ③ tophi; ④ uric acid kidney stones and (or) uric acid nephropathy; ⑤ hyperuricemia with renal insufficiency.

Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.

Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.